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Abstract: The antimicrobial properties of herbs from Papaveraceae have been used in medicine for
centuries. Nevertheless, mutual relationships between the individual bioactive substances contained
in these plants remain poorly elucidated. In this work, phytochemical composition of extracts from
the aerial and underground parts of five Papaveraceae species (Chelidonium majus L., Corydalis cava
(L.) Schweigg. and Körte, C. cheilanthifolia Hemsl., C. pumila (Host) Rchb., and Fumaria vaillantii
Loisel.) were examined using LC-ESI-MS/MS with a triple quadrupole analyzer. Large differences
in the quality and quantity of all analyzed compounds were observed between species of different
genera and also within one genus. Two groups of metabolites predominated in the phytochemical
profiles. These were isoquinoline alkaloids and, in smaller amounts, non-phenolic carboxylic acids
and phenolic compounds. In aerial and underground parts, 22 and 20 compounds were detected,
respectively. These included: seven isoquinoline alkaloids: protopine, allocryptopine, coptisine,
berberine, chelidonine, sanguinarine, and chelerythrine; five of their derivatives as well as non-
alkaloids: malic acid, trans-aconitic acid, quinic acid, salicylic acid, trans-caffeic acid, p-coumaric
acid, chlorogenic acid, quercetin, and kaempferol; and vanillin. The aerial parts were much richer in
phenolic compounds regardless of the plant species. Characterized extracts were studied for their
antimicrobial potential against planktonic and biofilm-producing cells of S. aureus, P. aeruginosa, and
C. albicans. The impact of the extracts on cellular metabolic activity and biofilm biomass production
was evaluated. Moreover, the antimicrobial activity of the extracts introduced to the polymeric carrier
made of bacterial cellulose was assessed. Extracts of C. cheilanthifolia were found to be the most
effective against all tested human pathogens. Multiple regression tests indicated a high antimicrobial
impact of quercetin in extracts of aerial parts against planktonic cells of S. aureus, P. aeruginosa, and
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C. albicans, and no direct correlation between the composition of other bioactive substances and the
results of antimicrobial activity were found. Conclusively, further investigations are required to
identify the relations between recognized and unrecognized compounds within extracts and their
biological properties.
Keywords: Chelidonium majus; Corydalis cava; Corydalis cheilanthifolia; Corydalis pumila; Fumaria
vaillantii; chelerythrine; coptisine; berberine; protopine; chlorogenic acid; quercetin
1. Introduction
The antimicrobial activity of Papaveraceae (poppy family) plants has been linked to
the presence of several classes of alkaloids such as phthalideisoquinolines or tetrahydropro-
toberberines and various polyphenolic compounds [1,2]. So far, most of the biological
activities of these plants referred to the type of natural compounds or their concentra-
tions [1,3]. Not much is known on the quiddity of individual compounds’ contribution
in plant extracts that result in its biological potential. Can we discuss the strength of the
biological activity in relation to the proportion between different bioactive metabolites
or their classes? Papaveraceae are rich in alkaloids among which isoquinoline-derived
structures constitute a large group. The family of Papaveraceae encompasses 44 genera and
about 825 species of herbaceous plants distributed in the temperate zone of the northern
hemisphere, in southern Africa, and in the western part of South America [4]. The APG
IV system divides this family into three subfamilies and five tribes [4]. Many species of
Papaveraceae have been used medicinally since ancient times. As medicinal raw materials,
Chelidonium majus, Fumaria species, and Corydalis species were described by Dioscurides
and Pliny the Elder in the first century AD, and under the names Chelidonion, Capnos,
and Aristolochia rotunda, these species were known to physicians until the end of the Re-
naissance [2,5,6]. Some of them are still used as traditional herbal medicines. Each of
the species represents its own phytochemical profile consisting of a varying number of
alkaloids, different kinds of phenylpropanoids, and minor compounds such as terpenoids,
saponins, and others. Regarding the alkaloids, it is the most diverse group of the phyto-
chemical constituents, among which many derivatives with slightly different structures are
observed [1,2]. The abundance of molecules of known or alleged antimicrobial potential
within medicinal plants from Papaveraceae is of paramount importance in the present
times, referred to as the “post-antibiotic era”, in which an increasing percentage of bacterial
strains have become resistant to two or more classes of antibiotics [7]. Apart from resistance
mechanisms, another adaptative microbial system is correlated with an increased risk of
antibiotic therapy failure. The majority of pathogenic bacteria form an adhered structure
referred to as the biofilm. This diversified community of microbial cells displays a high
tolerance to antibiotics due to the presence of a protective extracellular matrix, diversified
metabolism, and coordinated response systems [8]. The biofilm formed by such oppor-
tunistic pathogens as Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans is
known to have a highly detrimental impact on human health and it causes an increased
tolerance to antibiotics in comparison to their “planktonic” counterparts (non-adhered,
“free-swimming” cells) [9]. Bearing the above in mind, searching for novel antimicrobial
and antibiofilm compounds is of great importance in order to increase the therapeutic
success rate and decrease the economic burden related to ongoing, biofilm-based infections.
Therefore, in this work, we aimed to explore the similarities and differences in the
phytochemical profile and the antimicrobial/antibiofilm potential of isoquinoline alkaloid-
containing plants. We selected five species for the analysis, assigned to three different tribes
within one plant family.
Plants were chosen for the phytochemical comparative analysis on the basis of differ-
ences in their morphology and anatomy. Two of the Corydalis species, C. cava (L.), Schweigg.
and Körte, and C. pumila (Host), Rchb., develop bulbs as underground parts. One species,
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C. cheilanthifolia, Hemsl. known as the fern-leaved corydalis, develops tap roots, similarly
to the representatives of two other genera, Chelidonium majus L. and Fumaria vaillantii Loisel.
The detailed phytochemical composition of the aerial and underground parts was explored
using LCMS equipped with a triple quadrupole detector. Next, assays measuring the
impact of extracts against planktonic and biofilm-forming S. aureus, P. aeruginosa, and C.
albicans were performed. Finally, the extracts were chemisorbed within a polymeric carrier,
referred to as the bacterial cellulose (BC), to show, as the proof-of-concept, the potential
applicability of extracts as antimicrobial measures against localized infections.
2. Results
2.1. Phytochemical Analysis
Large differences in the quality and quantity of all analyzed compounds were observed
between species of different genera and also within one genus. Isoquinoline alkaloids
predominated in the phytochemical profiles and several phenolic compounds were also
present in smaller quantities.
2.1.1. Qualitative Analysis
A total of 22 compounds in aerial parts and 20 compounds in underground parts of
the five Papaveraceae species were detected. Twelve of them were identified in positive
and another ten in the negative electrospray ionization mode.
In extracts of the aerial and underground parts of C. majus, C. cava, C. cheilanthifolia,
C. pumila, and F. vaillantii, the following compounds were detected: seven isoquino-
line alkaloids: protopine, allocryptopine, coptisine, berberine, chelidonine, sanguinarine,
and chelerythrine; five of their derivatives: protopine derivative, coptisine derivative,
tetrahydrocoptisine, tetrahydroberberine, and chelidonine derivative; three non-aromatic
carboxylic acids: malic acid (dicarboxylic acid), trans-aconitic acid (polycarboxylic acid),
and quinic acid (cyclohexanecarboxylic acid); one hydroxybenzoic acid: salicylic acid; two
hydroxycinnamic acids: trans-caffeic acid and p-coumaric acid; one caffeic and the quinic
acid ester: chlorogenic acid; two flavonols: quercetin and kaempferol; and one phenolic
aldehyde: vanillin.
The assignment of the protopine derivative was based on a characteristic loss of the
m/z 320.2 fragment attributed to protonated protopine (Tables 1 and 2). Allocryptopine
exhibited the parent ion at m/z 369.6 and the product ions at m/z 352, 187.9, 290. The
chelidonine derivative showed the precursor ion at m/z 370 and the product ions at m/z 356
and 339. The most abundant precursor ion at m/z 340 was assigned for tetrahydroberberine
and at m/z 336.4 for berberine. Two of the coptisine derivatives showed the parent ion at
m/z 324, while for coptisine at m/z 320.1. Sanguinarine and chelerythrine assignment was
based on a characteristic loss of a fragments of m/z 332.1 and 348.1, respectively.
The presence of three carboxylic acids was detected on the basis of parent ions cor-
responding to malic acid (m/z 133.1), trans-aconitic acid (m/z 172.9), and quinic acid
(m/z 191). Hydroxybenzoic acid showed parent ions at m/z 137.3 corresponding to salicylic
acid. Trans-caffeic acid and p-coumaric acid identification was based on parent ions at m/z
179.2 and 163, respectively. Chlorogenic acid exhibited the parent ion at m/z 353 and a
characteristic loss of fragments corresponding to caffeic and quinic acids. The identification
of two flavonoids was based on the presence of the parent ion at m/z 301.1 corresponding
to quercetin and at m/z 285 to kaempferol. One phenolic aldehyde showed the parent
ion at m/z 151.2 and the product ions at m/z 136, 91.8, 108 corresponding to vanillin
(Tables 1 and 2).
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Table 1. Content [µg/g D.W. ± SD] of detected compounds in the aerial parts of C. majus, C. cava, C. pumila, C. cheilanthifolia, and F. vaillantii.
Number Compound Parent Ion (m/z) Production (m/z) Ion Mode Content [µg/g D.W. ± SD]
ALKALOIDS C. majus C. cava C. pumila C. cheilanthifolia F. vaillantii
1. Protopine derivative 354 320, 260, 196 + p p nd p p
2. Allocryptopine 369.6 352, 187.9, 290 + 22.77 ± 1.75 a 6.46 ± 0.70 b 49.14 ± 1.41 c 265.06 ± 3.73 d 5.96 ± 0.50 b
3. Coptisine 320.1 291.9, 204, 262 + 5455.79 ± 22.97 a 1820.82 ± 9.90 b 2.75 ± 0.05 c 5794.90 ± 22.72 d 76.73 ± 1.04 e
4. Berberine 336.4 320, 292, 321.1 + 83.02 ± 1.77 a 1.21 ± 0.07 b 60.70 ± 0.88 c 2696.04 ± 12.05 d 1.82 ± 0.05 b
5. Chelidonine derivative 370 356, 339 + p nd nd p Nd
6. Chelidonine 353.8 275, 189, 247 + 130.77 ± 2.80 a 1.85 ± 0.06 b 0.24 ± 0.01 b ndb 8.03 ± 0.07 c
7. Chelerythrine 348.1 332, 304, 333 + 22.55 ± 0.54 a 1.25 ± 0.09 b 4.78 ± 0.1 c 21.15 ± 0.25 d 2.04 ± 0.08 b
8. Tetrahydroberberine 340 176, 149 + p p p p p
9. Tetrahydrocoptisine 324 176, 149 + p p p p p
10. Coptisine derivative 324 190 + p p p p p
11. Sanguinarine 332.1 274.1, 316.9, 246 + 33.24 ± 1.67 a 2.53 ± 0.06 b 6.23 ± 0.06 c 57.22 ± 0.44 d 22.71 ± 0.3 e
12. Protopine 320.2 303.2, 107, 123.8 + 315.67 ± 6.06 a 136.52 ± 2.80 b 890.77 ± 1.97 c 748.43 ± 4.88 d 1083.21 ± 10.83 e
MISCELLANEOUS
13. Malic acid 133.1 115, 71 − p p p p p
14. Trans-aconitic acid 172.9 85, 129 − p p p p p
15. Quinic acid 191 85, 93 − p p p p p
16. Salicylic acid 137.3 93, 65, 44.8 − 3.05 ± 0.10 nd nd LOQ nd
17. Trans-caffeic acid 179.2 135, 134, 89 − 130.37 ± 4.06 a 52.89 ± 0.92 b 27.17 ± 1.27 c 16.05 ± 0.20 d 50.98 ± 1.84 b
18. Chlorogenic acid 353 191, 85, 92.9 − 159.84 ± 1.04 a 750.97 ± 2.68 b nd c 558.65 ± 11.03 d 82.37 ± 2.25 e
19. p-Coumaric acid 163.2 119.1, 93.1, 117 − 78.89 ± 2.58 a 10.04 ± 0.53 b 11.56 ± 0.66 b 1.05 ± 0.08 c 42.51 ± 1.65 d
20. Vanillin 151.2 136, 91.8, 108 − 15.54 ± 0.93 nd nd nd nd
21. Quercetin 301.1 151, 65, 121 − 1.75 ± 0.11 a 1.23 ± 0.02 a 26.20 ± 0.32 b 206.01 ± 1.13 c 262.36 ± 1.04 d
22. Kaempferol 285 169 − nd nd nd LOQ nd
Abbreviations: p—present, identification was based on mass spectra with no reference substances; nd—not detected; LOQ—limit of quantification; Means with the same superscript letter (a, b, c, d, or e) within
rows do not differ statistically at the significance level p ≤ 0.05 in Tukey’s test.
Molecules 2021, 26, 4778 5 of 20
Table 2. Content [µg/g D.W. ± SD] of detected compounds in the underground parts of C. majus, C. cava, C. pumila, C. cheilanthifolia, and F. vaillantii.
Number Compound Parent Ion (m/z) Production (m/z) Ion Mode Content [µg/g D.W. ± SD]
ALKALOIDS C. majus C. cava C. pumila C. cheilanthifolia F. vaillantii
1 Protopine derivative 354 320, 260, 196 + p LOQ p p p
2 Allocryptopine 369.6 352, 187.9, 290 + 147.96 ± 5.53 a 36.52 ± 1.25 b 699.72 ± 3.72 c 330.01 ± 2.46 d 9.26 ± 0.94 e
3 Coptisine 320.1 291.9, 204, 262 + 2744.21 ± 14.02 a 143.26 ± 1.66 b 10.24 ± 0.25 c 3605.56 ± 12.92 d 134.24 ± 2.22 b
4 Berberine 336.4 320, 292, 321.1 + 345.45 ± 5.76 a 16.85 ± 0.3 b 739.54 ± 3.41 c 176.03 ± 3.32 d 1.81 ± 0.03 e
5 Chelidonine derivative 370 356, 339 + p LOQ p nd nd
6 Chelidonine 353.8 275, 189, 247 + 1936.11 ± 15.48 a 13.69 ± 0.85 b nd c 6.74 ± 0.07 bc 48.58 ± 1.28 d
7 Chelerythrine 348.1 332, 304, 333 + 742.36 ± 4.63 a 11.26 ± 0.24 b 36.14 ± 0.89 c 48.28 ± 1.10 d 2.07 ± 0.06 e
8 Tetrahydroberberine 340 176, 149 + p p p p p
9 Tetrahydrocoptisine 324 176, 149 + p p p p p
10 Coptisine derivative 324 190 + p p p p p
11 Sanguinarine 332.1 274.1, 316.9, 246 + 915.56 ± 3.45 a 17.46 ± 0.49 b 28.30 ± 0.42 c 493.20 ± 3.87 d 45.56 ± 0.67 e
12 Protopine 320.2 303.2, 107, 123.8 + 586.48 ± 12.67 a 131.79 ± 1.56 b 1260.62 ± 13.93 c 6529.64 ± 13.88 c 3610.09 ± 9.71 d
MISCELLANEOUS
13. Malic acid 133.1 115, 71 − p p p p p
14. Trans-aconitic acid 172.9 85, 129 − p p p p p
15. Quinic acid 191 85, 93 − p p p p p
16. Salicylic acid 137.3 93, 65, 44.8 − nd nd nd nd LOQ
17. Trans-caffeic acid 179.2 135, 134, 89 − nd LOQ nd nd nd
18. Chlorogenic acid 353 191, 85, 92.9 − nd a 1198.03 ± 8.63 b nd a 51.18 ± 2.75 c 1.22 ± 0.06 a
19. Vanillin 151.2 136, 91.8, 108 − nd a nd a 12.4 ± 0.28 b 28.93 ± 1.03 c 18.71 ± 0.94 d
20. Quercetin 301.1 151, 65, 121 − nd a nd a nd a 205.54 ± 1.19 b 305.65 ± 1.78 c
Abbreviations: p—present, identification was based on mass spectra with no reference substances; nd—not detected; LOQ—limit of quantification; Means with the same letter (a, b, c, d, e) within rows do not
differ statistically at the significance level p ≤ 0.05 in Tukey’s test.
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2.1.2. Phytochemical Quantitative Analysis
In aerial parts of all five species allocryptopine was found in quantities ranging
between 5.96 and 265.06 µg/g of dry weight (D.W.), whereas in underground ones between
9.26 and 699.72 µg/g of D.W. (Tables 1 and 2).
Protopine was found in aerial parts of all plants in the range between 136.52 and
1083.21 µg/g of D.W. In underground parts, this compound was present in all studied
species in the wide range of 131.79–6529.64 µg/g of D.W. A protopine derivative was
present in all the studied species in both plant organs, except for the aerial parts of C. pumila.
The amounts of this compound remained unknown because the identification was based
only on mass spectra without an authentic reference substance (Tables 1 and 2).
Coptisine was detected in relatively large amounts compared to other alkaloids and
polyphenolic compounds. Its highest content was found in the aerial parts of C. cheilanthifo-
lia, followed by C. majus, C. cava, F. vaillantii, and C. pumila (5794.90, 5455.79, 1820.82 µg/g,
76.73 µg/g, and 2.75 µg/g, respectively). Relatively large amounts of this compound
were also present in the underground parts of C. cheilanthifolia and C. majus (3605.56 and
2744.21 µg/g, respectively). In turn, in both the aerial and underground parts of C. cava,
C. pumila, and F. vaillantii, coptisine was found in much lower amounts (Tables 1 and 2).
Tetrahydrocoptisine and an unidentified coptisine derivative were detected in all samples
but their absolute quantities remained unknown due to their identification being based
only on mass spectra with no reference substances (Tables 1 and 2).
Berberine was abundant in aerial parts of C. cheilanthifolia (2696.04 µg/g of D.W.) and
in the underground parts of C. pumila and C. majus (739.03 and 345.45 µg/g, respectively).
In the other species, it occurred only in much smaller amounts (Tables 1 and 2). In turn,
tetrahydroberberine was found in all samples but not quantified due to the lack of the
reference substance (Tables 1 and 2).
Chelidonine was found in C. majus in quite large amounts of 130.77 and 1936.11 µg/g
in aerial and underground parts, respectively. Smaller quantities of this compound were
found in underground parts of Fumaria vaillantii (48.58 µg/g of D.W.), C. cava (13.69 µg/g
of D.W.), and C. cheilanthifolia (6.74 µg/g of D.W.), whereas in C. pumila it was not detected.
In the aerial parts of C. cava, C. pumila, and F. vaillantii, it was present in the range of
0.24–8.03 µg/g of D.W. and not detected in C. cheilanthifolia. The Chelidonine derivative
was present only in the aerial parts of C. majus and C. cheilanthifilia, and in the underground
parts of C. majus, C. cava, and C. pumila (Tables 1 and 2). No quantitative analysis was
performed for this compound.
The largest amount of chelerythrine was found in the underground parts of C. majus
(742.36 µg/g of D.W.). In the remaining samples it was detected in smaller amounts
(1.25–48.28 µg/g of D.W.) (Tables 1 and 2).
Sanguinarine was found in large amounts in underground parts of C. majus and C.
cheilanthifolia (915.56 and 493.20, respectively), and in the rest of plant samples in the range
of 2.53–57.22 µg/g of D.W. depending on the plant species (Tables 1 and 2).
Generally, much lower amounts of phenolic compounds were found compared to
the amounts of alkaloids and they were mainly present in the aerial parts. Salicylic
acid was found in a detectable amount of 3.05 µg/g of D.W. only in aerial parts of C.
majus. (Table 1). Trans-caffeic acid, chlorogenic acid, and p-coumaric acid were present
in aerial parts of almost all the plants in the amounts of 16.05–130.37, 82.37–750.97, and
1.05–78.89 µg/g of D.W., respectively (Table 1). Additionally, in the underground parts of
C. cava, a considerably large quantity of chlorogenic acid was found (1198.03 µg/g of D.W.)
(Table 2).
Vanillin was found only in aerial parts of C. majus (15.54 µg/g of D.W.) and in under-
ground parts of C. pumila, C. cheilanthifolia, and F. vaillantii in amounts of 12.4, 28.93, and
18.71 µg/g of D.W., respectively (Table 2).
Quercetin was detected in aerial parts of all the examined species in amounts between
1.23 and 262.36 µg/g of D.W., with the highest content in C. cheilanthifolia. In the under-
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ground parts, it was found only in C. cheilanthifolia and F. vaillantii (205.54 and 305.65 µg/g
of D.W., respectively) (Table 2). In aerial parts of the former species, another flavonoid,
kaempferol, was detected but its content was at the limit of quantitation (Table 1).
Other polyphenolic compounds were mainly present in the aerial parts of the studied
plants in quantities that did not allow for their quantification.
2.2. The Antimicrobial Assays
The results of antimicrobial assays against planktonic cells showed that the extract
of the C. cheilathifolia herb acted not only against all tested pathogens (C. albicans, P. aerug-
inosa, and S. aureus), but was also the most effective in the aspect of the concentration
applied (MIC at 50%, 25%, and 6.25%, respectively) (Figure 1A). The minimum inhibitory
concentrations of other extracts were not lower than 50% or the MIC was not reached in
a concentration of least 50% against all microbial strains, with one exception of C. cava
bulbs (MIC at 25% against S. aureus) (Figure 1A). Conversely, all extracts that did not reach
the MIC threshold still displayed noticeable reduction rates against analyzed microbes
(Figure 1B–D). In the cases of S. aureus, P. aeruginosa, and C. albicans, reduction rates for
these extracts oscillated around 30-70%, 40-80%, and 70-80%, respectively.
Figure 1. (A) Minimum inhibitory concentration (MIC (%)) of extracts against planktonic microbial cells. Dashes (−)
indicate extracts in which the MIC values were not reached in the highest concentration (50%) of the extract applied.
(B–D) Reduction of planktonic cell count below MIC’s threshold after the exposure to extracts, measured for S.aureus,
P.aeruginosa, and C.albicans (in (B–D), respectively). Abbreviations: R—roots, H—herb, and B—bulbs.
The investigations on the antibiofilm activity showed a higher impact of the analyzed
extracts on the number of S. aureus and C. albicans biofilm-forming cells (and their metabolic
activity) than on the biofilm biomass (which comprises of cells and the biofilm extracellular
matrix). Although the highest-to-achieve concentration of extracts (50% (v/v)) did not lead
to the complete (100%) killing of S. aureus and C. albicans cells (thus it may not be considered
the minimal biofilm eradication concentration), the reduction rate in the case of C. albicans
was high (above > 92%). It is also noteworthy that the opposite trend was observed in
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the case of P. aeruginosa; the application of extracts repeatedly increased the metabolic
cellular activity of the biofilm of this pathogen. The high diversification was observed
with regard to the part of the plant applied. In the case of S. aureus, the underground
parts’ extracts of only two species (C. majus and F. vaillantii) were more effective than those
of the aerial parts (Table 3). In turn, the herb extracts of C. cheilathifolia, C. pumila, and
C. cava, used in the concentration of 50%, more effectively eradicated S. aureus cells than
the underground parts’ extracts (Table 3). Results of the multiple regression test (Table 4)
indicated that, with regard to planktonic cells, quercetin had the highest impact on the
results obtained against all microorganisms analyzed. No similar tendency (high impact of
one compound against all microorganisms) was observed in other experimental settings
(underground parts vs. planktonic cells or biofilms). This suggests an influence of the
compounds’ mixture on antimicrobial results. Nevertheless, in the case of P. aeruginosa, the
allocryptopine extracted from underground parts should be distinguished, as its presence
correlated with antimicrobial results against this pathogen (Table 4). The antimicrobial
activity of extracts released from bacterial cellulose carrier, used during examination,
indicated C. cava and C. cheilathifolia to be the most effective against S. aureus and C. albicans
(Table 5).
Table 3. Percentage reduction (%) of biofilm cells treated with extracts in the concentration of 50% (v/v) using the TTC and
crystal violet (CV) method. The untreated control setting was established as 100% of microbial bacterial activity or biofilm
biomass (method using TTC and CV, respectively). Please note that in the case of P.aeruginosa, the exposure on extracts led to
an increase of metabolic activity measured by the TTC method; in the case of the biofilm assessment using the crystal violet
assay, the results are not shown (n.s.) due to the low usability of this particular plate-based technique for pseudomonal
biofilm analysis, as discussed in the later part of this manuscript. Abbreviations: R—roots, H—herb, and B—bulbs.
Plant Material
Reduction of Biofilm-forming Cell
Number [TTC Assessment]
Reduction of Biofilm Biomass
[Crystal Violet Assessment]
S. aureus P. aeruginosa C. albicans S. aureus P. aeruginosa C. albicans
C. majus R 71.79 −179.81 95.69 10.84 n.s 66.63
H 26.11 −200.74 93.72 20.41 n.s 65.02
F. vaillantii
R 67.01 −97.61 92.92 24.29 n.s 66.20
H 52.42 −94.27 95.04 20.81 n.s 65.27
C. cheilanthifolia R 70.02 −177.17 93.55 7.63 n.s 74.64
H 89.10 −194.71 93.85 10.99 n.s 68.92
C. pumila B 66.84 −395.46 92.06 11.21 n.s 54.99
H 82.74 −276.47 94.40 25.20 n.s 58.86
C. cava
B 67.61 −105.26 95.78 11.04 n.s 62.54
H 74.53 −84.47 95.70 22.12 n.s 67.14
Table 4. Multiple regression-estimation of the influence of the variable on the model.
S. aureus P. aeruginosa C. albicans









Quercetin 0.699 −0.614 0.000 Quercetin 0.965 −0.984 0.000 Berberine 0.960 −0.748 0.000
Chlorogenic
Acid 0.219 0.524 0.000 Coptisine 0.021 −0.268 0.003
Sanguinarine 0.072 −0.322 0.001 Quercetin 0.010 −0.131 0.036
Biofilm/TTC p-coumaricAcid 0.781 −0.525 0.030 Exclusion of Data from Model Chelerythrine 0.628 −0.818 0.004
Biofilm/Crystal












Allocryptopine 0.340 0.892 0.001 Chelidonine 0.537 −0.487 0.020 Coptisine 0.825 −0.817 0.002
Chlorogenic
Acid 0.478 0.757 0.004 Allocryptopine 0.318 0.537 0.007
Biofilm/TTC
Sanguinarine 0.533 0.690 0.015 Allocryptopine 0.869 −0.869 0.002 Vanillin 0.478 −0.308 0.003
Quercetin 0.033 0.192 0.000 Berberine 0.233 −0.233 0.005
Sanguinarine 0.160 0.667 0.000
Chlorogenic
Acid 0.121 0.615 0.000
Biofilm/Crystal
Violet Statistical Model Insignificant Exclusion of Data from Model Statistical Model Insignificant
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Table 5. Diameters of growth inhibition obtained by the disc diffusion method (mm). The diameters of the cellulose
membranes were 14 mm. The release of extracts other than those obtained from C. cheilanthifolia H and C. cava H did not
translate into the formation of the zone of growth inhibition.
Plant Material Volume of Extract [mL] Concentration of Extract [mg/mL]
Zone of Growth Inhibition [mm]
S. aureus P. aeruginosa C. albicans
C. cava H 0.9 21.76 19 0 0
C. cheilanthifolia H 1 22.8 21 22 0
3. Discussion
The comparative analyses of the chemical composition of the selected plant species
and the results of their antimicrobial activity indicated that the biological potential of
these plants does not depend solely on the content of any individual constituent. The
studied species represent two subfamilies within the Papaveraceae, i.e., Fumarioideae
Eaton with the genera Fumaria L. and Corydalis D.C., and Papaveroideae (Chelidonium
majus). Fumarioideae, unlike Papaveroideae, do not produce latex, although laticifer tubes
are developed in collateral vascular bundles, the cortex, and the sclerenchymatous sheath
of Fumaria densiflora stem [10]. About 400 species belong to the Corydalis genus. These are
plants widespread in Europe, Asia, North America, and northern, eastern, and southern
Africa. Most species are native to China and the Himalayas [4]. They are usually perennials
that develop racemose inflorescences with monosymmetric flowers and underground
bulbs. However, some species develop a tap root.
In this study, the extracts of three Corydalis species were the most effective against S.
aureus and Candida sp., among which both aerial parts and root extracts of C. cheilanthifolia
had the strongest antimicrobial effect. Simultaneously, these extracts were rich in isoquino-
line alkaloids such as protoberberine and protopine derivatives (Tables 1 and 2). The aerial
parts also contained relatively large amounts of chlorogenic acid, quercetin, and kaempferol,
and smaller amounts of trans-caffeic acid and p-coumaric acid (Tables 1 and 2). Previous
studies on this species revealed the presence of the same alkaloids [11]. In addition, other
alkaloids were detected such as ophiocarpine, (−)-canadine, (−)133-hydroxystylopine,
(−)-canadine methohydroxide, and stylopine, as well as trans-ferulic acid. However, the
mentioned study was only qualitative and used only the aerial parts. The results of our
analysis additionally indicated the presence of phenanthridine derivatives such as san-
guinarine and chelerythrine, as well as quercetin, chlorogenic acid, and vanillin in the roots
(Tables 1 and 2). C. cheilanthifolia is a short-lived perennial native to the western provinces
of China, growing on shady slopes at an altitude of 800–1700 m above sea level. Unlike
many other Corydalis species, it does not produce bulbs, only a tap root.
It is interesting that the second most effective were the two other Corydalis species,
C. cava and C. pumila (Tables 1 and 2). C. cava is an early spring geophyte associated with
European oak-hornbeam forests. The bulb of this species is large with roots growing all
over its surface and hollow in older individuals. The C. cava phytochemical profile was
rather poor in terms of the complexity and quantity of alkaloids and phenolic compounds,
with an exception of chlorogenic acid (Tables 1 and 2). A similar but only qualitative
phytochemical profile of the aerial parts of C. cava was observed by Adsersen et al. [12]
based on thin-layer chromatograms. Allocryptopine was also found in C. cava by Slavik
and Slavikova [13], while Och et al. [14] did not detect this compound at all. Additionally,
a secoberbine alkaloid, (−)-canadaline, was isolated and identified in the bulbs of C. cava
by Meyer and Imming [15]. The molecular weight and molecular formula are the same
as for allocryptopine. This may cause discrepancy between different studies. We did not
detect (−)-canadaline in the examined plant material, while allocryptopine was identified
using the reference substance. Coptisine was previously identified in C. cava bulbs by Och
et al. [14] in a moderate relative content of 15–30% based on the peak area at 270 nm with
no reference standard. It was also isolated in small amounts from bulbs by Slavik and
Slavikova [13] and Gasic et al. [16]. We have detected this compound only in aerial parts,
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while Preininger et al. [17] noted it as a minor compound. In 2012, a new alkaloid named
corylucinine was also isolated from C. cava bulbs [18]. It may be involved in bioactivity but
we have not detected it in our plant material.
In turn, in the phytochemical profile of C. pumila, aerial parts were dominated by
protopine and in the underground parts by allocryptopine, berberine, and protopine
(Tables 1 and 2). Both plant parts were poor in phenolic compounds. Only small amounts
of caffeic acid, p-coumaric acid, and quercetin were found (Tables 1 and 2). Unfortunately,
no other studies could be found to compare with our results of C. pumila, a sub-Atlantic
species found in Europe from southern Scandinavia and through Central Europe to the
Balkans and Corsica. In Poland, it is a vulnerable (VU) species growing only in a few
localities in the western part of the country. It grows in mixed forests, most often in moist
oak-hornbeam forests. The bulb is small, solid inside, and renews every year. In the
spring, the old bulb cambium sets a new bulb and the old one is reduced to thin structures
surrounding the new bulb [19].
Two further species (C. majus and F. vaullantii) showed moderate and low antimi-
crobial activity. The extracts from the underground parts showed stronger antibacterial
and antifungal activity against planktonic and biofilm cells. Roots of F. vaillantii were
characterized by a relatively rich phytochemical profile (Table 2). They contained alkaloids
from three classes, i.e., protopine, protoberberine, and phenanthridine derivatives, and
their content was several times higher than in the aerial parts (Table 1). Previous studies
of this species have shown the presence of several classes of isoquinoline alkaloids such
as benzylisoquinoline, spirobenzylisoquinoline, phthalideisoquinoline, morphinandiene,
protoberberine, protopine, and benzophenanthridine derivatives [15,20–28], as well as
quercetin [29]. In addition, several other classes of phytochemicals were detected using
obsolete unspecific methods [30]. Among different compounds, fumaric acid found in F.
vaillantii was indicated as potentially responsible for the antimicrobial activity [30] but no
other compounds were examined in this reference. F. vaillantii grows in Europe, Turkey,
the Middle East, the Caucasus, Iran, Central Asia, northwest Africa, and Libya [31]. It is
an archeophyte originating in the Irano-Turan area. In Poland, it is a rare species and is
classified as vulnerable (VU). Due to its morphologic resemblance to the pharmacopeia-
listed species Fumaria officinalis, there is a risk of misidentification of the herbal material
when collected from wild habitats. Therefore, the data on their phytochemical profiles are
important for pharmaceutical quality.
C. majus roots were found to be the richest source of isoquinoline alkaloids in terms of
their quality (Table 2). Seven alkaloids of various classes and their derivatives have been
found in both aerial and underground parts. The former contained significantly lower
amounts of phenanthridine derivatives. The content of sanguinarine and chelerythrine
in the aerial parts was several dozen times lower than in the roots (Tables 1 and 2). In
turn, the coptisine content was twice as much as in the roots (over 5 mg/g, Table 1).
Most of the previously published papers on C. majus concern almost exclusively the
presence of isoquinoline alkaloids. However, the raw material harvest period is often
not defined, thus the alkaloid contents are presented in considerably varying amounts.
This issue has been discussed in details in a recent review by Zielińska et al. [2]. Our
current research showed that both the C. majus herb and its roots harvested in April are
rich in coptisine. In the previous one [3], such large amounts of coptisine were noted
only for aerial parts, especially fruits, but the plant material was harvested in autumn
(September). A large proportion of this compound was also detected in shoot cultures of C.
majus, while root cultures were rich in sanguinarine [32]. Larger proportions of chelidonine,
chelerythrine, and sanguinarine in roots were also observed by Tome and Colombo [33].
Considering polyphenolic compounds in C. majus, only a few reports in the literature exist.
In our study, the C. majus herb contained several polyphenolic compounds, among which
hydroxycinnamic acids such as trans-caffeic acid, p-coumaric acid, and chlorogenic acid
were the most abundant (Table 2, Figure 2). Caffeic, p-coumaric, p-hydroxybenzoic, caffeoyl-
threonic acid, caffeoyl-glyceric acid, and caffeoyl-malic acid were previously identified
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in C. majus [34–36]. Additionally, in the study by Grosso et al. [34] two flavonoids, i.e.,
quercetin and kaempferol and their derivatives, were detected. Genus Chelidonium L.
belongs to the tribe Chelidonieae Dumortier of the subfamily Papaveroideae Eaton and is
comprised of only two species: C. majus and C. asiaticum (Hara) Krahulc. [4,37]. C. majus is
a short-lived perennial native to temperate areas of Europe and Asia (Erhardt et al., 2002).
The natural habitat of C. majus are deciduous forests, brushwood, and ruderal sites with
a high content of organic matter and nitrogen in the soil. Both herbs, as well as the roots
of celandine, produce orange latex, visible after injury to the plant. As a pharmacopeial
species growing wild and cultivated in many regions, knowledge of the phytochemical
diversity and correlating it to potential bioactivity is of high importance.
Figure 2. Zones of the inhibition of growth of (A) C. albicans and (B) S. aureus as the result of the release of the C. cheilanthifolia
herb extract from the BC carrier. Please note that in the case of (C) P. aeruginosa, no inhibition zone was observed despite
visible release (oval zone of dark color) of extract from the BC carrier. Pictures (A1–C1) are at 3x magnification of the
BC carriers and inhibition zones (in the case of picture (A1,B1), and lack of zone in the case of (C1)) from pictures (A–C),
respectively.
When considering the content of individual compounds, allocryptopine was found
in all five examined species, although its amounts were higher in underground parts
(Tables 1 and 2). Protopine and coptisine were the metabolites with the largest quantitative
differences between the examined plant species. Unfortunately, due to the lack of reference
substances, it was impossible to identify these compounds more accurately and quantify
them.
The analysis of the polyphenolic compounds generally showed that they were more
characteristic for the aerial parts of the studied plants (Table 1, Figure 2). However, it is
difficult to clearly indicate how the phytochemical profile of the studied plants translates
into their antimicrobial activity. The assays against planktonic C. albicans and S. aureus
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revealed a stronger effect of the extracts from the underground parts of all the studied
species and in C. cheilathifolia, C. pumila, and F. vaillantii against P. aeruginosa.
In turn, the stronger effect of the extracts from the underground parts against plank-
tonic P. aeruginosa cells was visible in the case of three out of five plants tested (C. cheilathifo-
lia, C. pumila, and F. vaillantii). The underground parts of C. majus and F. vaillantii and aerial
parts from all Corydalis species were more effective against the S. aureus biofilm (Figure 1,
Table 3).
If one of the identified compounds was identified as having the highest impact alone
on the antimicrobial result, it would be quercetin but only with regard to planktonic
P. aeruginosa cells. This coincides with the recent work of Kho et al. [38]. However,
contrary to aforementioned work, our results do not indicate the antibiofilm potential of
quercetin against P. aeruginosa. This apparent discrepancy may be explained by the fact
that quercetin acts in a strain-dependent manner and its concentration may be too low to
eradicate the biofilm of this particular reference pseudomonal strain we used in our study.
However, various phenolic compounds including flavonols and phenolic-rich extracts
are often reported for their general antimicrobial properties [39–42]. It is noteworthy that
the results concerning the biofilm of P. aeruginosa indicate an increase of the metabolic
activity of cells (Table 3) after exposure to extracts. This phenomenon requires further
experimental studies; at the moment, a few hypotheses (requiring empirical confirmation)
can be proposed. The first of them is related to the stimulating impact of so-called sub-
optimal (referred to as sub-MIC) antimicrobials’ concentrations on the metabolic activity of
pseudomonal biofilm shown, among others, by the team of Hemati et al. [43]. The second
one is related to the reported ability of members of the Pseudomonadaceae family (referred
to as the P. entomophila) to secrete isoquinoline alkaloids similar in chemical structure to
berberine and sanguinarine from Papaveracae [44]. Considering the high genetic similarity
of Pseudomonadaceae members [45], it may be assumed that together with the ability to
produce isoquinoline alkaloids, aforementioned bacteria including the P. aeruginosa species
developed also specific mechanisms to neutralize alkaloids’ biocidal impact against its own
cellular structures. Their activation and subsequent energy consumption may translate
into observed high metabolic activity. The third hypothesis assumes that specific molecules
or their mixtures from the analyzed samples are responsible for the up-regulation of one
of the energy-producing metabolic pathways within pseudomonal cells. If it is so, such
specific molecules or molecules’ mixtures could be possibly applied in the biotechnological
industry, utilizing pseudomonal cells for a number of applications including biosurfactant
production [46].
In regard to the underground parts, the applied multiple regression model (Table 4)
indicated that allocryptopine was a molecule of significant potential for the eradication
of bacterial (P. aeruginosa, S. aureus) cells but not of C. albicans. Nevertheless, all other
molecules than the already mentioned quercetin and allocryptopine, which had an impact
on the observed reduction of the microbial count, were of known antimicrobial activity.
These include chlorogenic acid, sanguinarine, berberine, coptisine, p-coumaric acid, chelery-
thrine, chelidonine, allocryptopine, sanguinarine, and vanillin (Table 4). These compounds
act through a variety of mechanisms of which two groups should be distinguished, namely
the destruction of the bacterial membrane or DNA replication inhibition groups [47–50].
The above results show that the observed antimicrobial effect is predominately mediated
by the composition of active molecules within extracts and their mutual interactions that
may occur during the process of interplay with microorganisms. Therefore, it seems to
be crucial in the next line of investigation to analyze the activity of all these molecules
alone and coupled with assessing which applied combination acts in an antagonistic and
synergistic manner with regard to observed antimicrobial effect.
The results presented in this work show the promising potential of Papaveracae plants
to be applied as a source of novel antimicrobial and antibiofilm drugs, and simultaneously
demonstrate that specific microbial species (P. aeruginosa) may exhibit contrary types of
responses to extracts, i.e., to increase metabolism (Table 3). It may affect the therapeutic
Molecules 2021, 26, 4778 13 of 20
indications and can potentially cause adverse effects if used against unsusceptible bacterial
strains. Therefore, further study is necessary to verify the often-seen claims of general or
wide-ranging antibacterial properties of berberine and related alkaloids. There are also
other limitations of this study that require further action before there is a direct translation
of the obtained results into the clinical setting.
The first of them is the number of microbial strains analyzed. Undoubtedly, the
analysis of a few dozen of strains from each species would allow to scrutinize applied
extracts with regard to the inter and intra-species tolerance to active compounds present in
extracts and shed light on their exact potential applicability in fighting against the infection
process. The second of them is related to results presented in Figure 2, Table 5. One should
note that the majority of extracts released from the BC carrier were ineffective against
lawn-seeded cells, in contrast to the results presented in Figure 1 and Table 3. It may
indicate the interactions (bonding) between the applied carrier and bioactive molecules of
extracts. The application of another carrier or functionalization of the BC carrier would be
necessary if such bonding was confirmed in subsequent studies. The third disadvantage
is of a strictly methodological character and concerns the methods of the pseudomonal
biofilm culturing in a 96-well plate setting. As we and other teams reported earlier [51–55],
the commonly acknowledged microtiter plate methods, although applicable for the testing
of biofilms localized and firmly adhered to the bottom of the plate well (as in the case of S.
aureus or C. albicans), are of low applicability for analyses of slime-forming (and filling the
whole volume of the plate well) biofilms of the Enterobacteriacae or Pseudomonas family. The
subsequent procedures of rinsing and washing that are necessary to perform the crystal
violet assay often lead to the random removal of the pseudomonal biofilm and to bias
the results of high standard deviations. Therefore, although we performed such a test,
we deliberately did not include it in the manuscript. In turn, we presented data from the
metabolic (TTC) assay for analyses of the pseudomonal biofilm because this technique
allows to avoid the aforementioned disadvantages to some extent. As it was shown by
Grela et al. [56], the tetrazolium-based test, if performed with precautions, allows not
only to localize and quantify the biofilm structure but also to determine the presence of
live bacteria within. Despite the above-mentioned limitations, the results of this study
indicate the antimicrobial or microbiologically modulating potential of the high number of
bioactive molecules isolated from Papaveracae plants, which are of high application for
further studies aiming to discover the new non-antibiotic counter-measures useful for the
eradication of nosocomial strains.
4. Materials and Methods
4.1. Plant Material
Five different plant species from the Papaveraceae family were collected from the Botan-
ical Garden of Medicinal Plants in Wroclaw (BGMP), geographical location: 51◦07′01.6′′ N
17◦04′26.7′ ′ E 51.117121, 17.074088. These were Chelidonium majus, Corydalis cava, Corydalis
cheilanthifolia, Corydalis pumila, and Fumaria vaillantii. Detailed edaphic data on the plants’
locations are as follow: Corydalis cava-soil with a thick layer of humus, well-drained, not
moist, not sandy, with a small amount of debris; Corydalis pumila-soil with a thick layer of
humus, well-drained, not moist, not very sandy; Corydalis cheilanthifolia-sandy soil, well-
drained, with very low humus content; Fumaria vaillantii-anthropogenic soil with debris,
with a thin humus layer on the surface, permeable; and Chelidonium majus-soil, very sandy,
well-drained, slightly moist with a thin humus layer. Meteorology data obtained from
the Polish Institute of Meteorology and Water Management, National Research Institute
(IMGW Wrocław-Strachowice station) for April 2018 include: the average daily temper-
ature of 14.0 ◦C; total rainfall of 31.4 mm; insolation of 284.3 h; absolute maximum daily
air temperature (at a height of 2 m) of 27.2 ◦C; absolute minimum daily air temperature
(at a height of 2 m) of −1 ◦C; absolute minimum daily air temperature at the ground (at a
height of 5 cm) of −3.8 ◦C; and data indicating two days with frost occurring in the first
week of April 2018.
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Plants were harvested in spring during the flowering period between 10th and 27th
of April 2018 (C. majus on 04/27; C. cava, C. cheilanthifolia, and C. pumila on 04/10; and F.
vaillantii on 04/21). Voucher specimens of the species were deposited in the Herbarium
of Botanical Garden of Medicinal Plants, Wroclaw Medical University, under the codes:
L02/C.m.1–15/18, L01/C.c.1–9/18, L01/C.ch.1–11/18, L01/C.p.1–11/18, and L01/F.v.1–
10/18.
Whole plants were dried at the temperature of 35 ◦C, separated into aerial and under-
ground parts, and intended for extraction.
Plant Material Extraction
Dried aerial and underground parts (200 mg) of the plants were separated, grounded
to powder using a mortar and pestle, and extracted with pure methanol and 0.1% formic
acid using an ultrasonic bath (2 × 30 min) in a total volume of 5 mL. The extracts were
prepared according to the modified procedure used in our previous studies [57,58].
4.2. Phytochemical Analysis
4.2.1. Chemical and Reagents
LC-MS grade methanol, water, and an eluent-additive LC-MS ultra-ammonium for-
mate (NH4HCO2) were purchased from Fluka Analytical (St.Louis, MO, USA).
Berberine (purity ≥ 95%), protopine (purity ≥ 95%), sanguinarine (purity ≥ 90%),
chelerythrine (purity ≥ 90%), and chelidonine (purity ≥ 95%) were purchased from Ex-
trasynthese (Genay, France), while coptisine (purity ≥ 98%), allocryptopine (purity ≥
98%), tr-caffeic acid, p-coumaric acid, chlorogenic acid, vanillic acid, salicylic acid, vanillin,
quinine sulphate, and quercetin were purchased from Sigma-Aldrich (St. Louis, MO, USA).
4.2.2. Liquid Chromatography
For the identification and quantification of the compounds, we used liquid chromatography-
electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) with a triple quadrupole
analyzer. The chromatographic separation was performed using a Shimadzu Prominence
UFLC system (Shimadzu, Kyoto, Japan) equipped with a LC-30 ADXR binary solvent
manager; DGU-20A3 degasser; CTO-10ASVP column oven; Kinetex C18 column, 2.6 µm
particle size, 100× 3.0 mm (Phenomenex, Torrance, CA, USA); SIL 20AXR autosampler; and
CBM-20A system controller interfaced to a triple quadrupole analyzer. The separation was
performed using reversed phase conditions. The mobile phase consisted of mixture A–B:
10 mM ammonium formate in water (A) and 0.1% formic acid in methanol (B). The methanol
percentage was changed linearly as follows: 0 min, −10%; 10 min, −85%; 13.01 min, −85%;
and 16 min,−10% at a flow rate of 0.40 mL min−1. The column temperature was maintained
at 35 ◦C. The sample volume (10 mL) was injected in the UHPLC system.
4.2.3. Mass Spectrometry
The tandem mass spectrometer LCMS-8030 (Shimadzu, Kyoto, Japan) with a triple
quadrupole analyzer equipped with an electrospray ionization (ESI) source working in
both positive and negative ionization modes was used for the analysis of alkaloids and
polyphenolic compounds.
Nitrogen dried and nebulized gas obtained from pressurized air in a N2 LC-MS
pump, working at a flow rate 15 L min-1 and 3 L min-1, respectively. The desolvation
line temperature was 250 ◦C and the heat block temperature was 400 ◦C. The collision
induced dissociation gas (CID) was argon 99.99% (Linde, Wrocław, Poland) at a pressure
of 230 kPa. A dwell time of 10 ms was selected. LabSolution Ver. 5.6 (Shimadzu, Kyoto,
Japan) software was used to process the quantitative data.
4.2.4. Identification and Quantification
A full scan together with MS/MS spectra was obtained during the flow injection
analysis (FIA) of each reference substance. The identification and quantification of analytes
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was performed using a multiple reaction monitoring (MRM) mode. The compounds’
identification was accomplished with the ion intensity ratio and retention time compared
with the corresponding standards and the previously identified alkaloids and phenolic
acids reported in the literature (for compounds 1, 5, 8, 9, and 10, shown in Tables 1 and 2
from Grosso et al. [34]; for compounds 13 and 14 from Bylund et al. [59]; and for compound
15 from Erk et al. [60]). The content of the compounds was expressed in µg per g of plant
material dry weight (D.W.).
The limit of the compounds’ detection (LOD) was calculated according to a signal-to-
noise ratio (S/N) of 3 and the limit of the compounds’ quantitation (LOQ) was calculated
according to the S/N ratio of 10. Linearity was evaluated from the square correlation
coefficients (r2) of the regression curves performed for each reference substance (r2 ≥ 0.99
was achieved for all compounds).
4.3. Antimicrobial Assays
Prior to the performance of the antimicrobial tests, dried plant extracts were diluted
with methanol and 0.1% formic acid (1:4, v/v).
4.3.1. Assessment of the Minimal Inhibitory Concentration of the Analyzed Extracts
The antimicrobial activity of the extracts was determined using the MIC (minimum
inhibitory concentration) assessment. Three reference strains from the American Tissue
and Cell Culture Collection were analyzed: Staphylococcus aureus ATCC 6538, Pseudomonas
aeruginosa ATCC 15442, and Candida albicans ATCC 10231. Initially, 100 µL of TSB (Tryp-
ticasein Soy Broth, Biomaxima, Lublin, Poland) medium was added to all the wells of a
96-well microtitration plate (Nest, China) except the first column. Subsequently, 200 µL of
the extracts were added to the empty wells and geometrically diluted. Next, 24 h bacte-
rial/fungal liquid cultures were adjusted to the 0.5 McFarland (MF) standard and diluted in
TSB medium to 105 colony-forming units (CFU)/mL on the basis of a previously performed
calibration curve to mimic the concentration of microbes able to cause the adverse effects
on human health. Then, 100 µL of the suspensions were poured into each well and the plate
was incubated at 37 ◦C, shaken (400 rpm/min.) for 24 h. Control of the microorganisms’
growth (medium with cells) and antimicrobial activity of the methanol (Chempur, Poland)
and 0.1% formic acid (Chempur, Poland) mixture, in a ratio of 1:4 (v/v), samples were
also performed. Subsequently, 20 µL of the 1% solution of triphenyl tetrazolium chloride
(TTC, 2,3,5-triphenyl-2H-tetrazolium chloride, Sigma Aldrich, Darmstadt, Germany) was
added to the wells and incubated for 2 h at 37 ◦C. The MIC values were assessed as the
first wells in which no red color was observed. Moreover, absorbance was measured before
and after incubation at the wavelength λ = 580 nm using a spectrophotometer MultiScan
Go (Thermo Fischer Scientific, Waltham, MA, USA). The absorbance measurements were
performed in two separate experiments and backed-up with a visual assessment of the TTC
reduction into red formazane. The results are presented as a precentage of cell reduction
calculated by the formula:
Cell reduction [%] = 100% − [Ab E/Ab PC × 100%] (1)
Abbreviations: Ab E—absorbance of samples measured after incubation cells with extracts
and Ab PC—absorbance of samples measured after incubation cells with medium only.
Furthermore, 5 µL of the solution was taken from each well and cultured onto the
Mueller–Hinton agar plates (Graso, Poland). The plates were incubated for 24 h at 37 ◦C
and the MBC (minimum bactericidal concentration) values were evaluated as the first well
in which no growth was observed.
4.3.2. Assessment of the Antibiofilm Activity of the Analyzed Extracts
The antibiofilm activity of the 2-fold diluted extracts was assessed. Firstly, 100 µL
of the bacterial/fungal suspensions prepared as described above were introduced to a
96-well microtitration plate (Nest, China) containing 100 µL of TSB (Trypticasein Soy Broth,
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Biomaxima, Lublin, Poland) medium in each well. After the plate incubation for 24 h at
37 ◦C, the medium was replaced with 200 µL of 50% concentration of the extracts, medium
(positive control), or the solvent and incubated for 24 h at 37 ◦C. Then, the medium was
removed again. Next, the number of metabolically active cells and the amount of formed
biofilm were evaluated using Richard’s technique and the crystal violet biofilm assay,
respectively. The first mentioned test was conducted as follows: 200 µL of 0.1% TTC
(2,3,5-triphenyl-2H-tetrazolium chloride, Sigma Aldrich, Darmstadt, Germany) solution
was added and the plate was incubated for 2 h at 37 ◦C. The medium was replaced with the
same volume of methanol (Chempur, Poland) and the plate was shaken at RT for 30 min.
100 µL of the solution was transferred to a fresh plate and the absorbance was measured at
the wavelength λ = 490 nm (spectrophotometer MultiScan Go (Thermo Fischer Scientific,
Waltham, MA, USA).
To quantify the biofilm formation using crystal violet methodology, the plate was
dried for 10 min at 37 ◦C. Then, 100 µL of 20% solution of crystal violet (CV, Aqua-med,
Poland) was poured into the plate and incubated for 10 min/RT. After the dye was removed,
the biofilm was washed twice with 100 µL of saline and the plate was dried for 10 min.
Next, 100 µL of 30% solution of acetic acid (Chempur, Poland) was added and the plate
was incubated at RT with shaking for 30 min. The solution was transferred to a separate
plate and absorbance was measured spectrometrically at the wavelength λ = 550 nm. The
reduction of biofilm cells was calculated as it was presented for the MIC evaluation. There
were two replications performed for each method.
4.3.3. Bacterial Cellulose Carrier Preparation
The most active extracts were also examined by the disc diffusion method. Instead
of standard paper discs, we applied bacterial cellulose polymers, obtained as follows
(Krasowski et al. [53]).
A Komagataeibacter xylinus ATCC 53524 strain was cultured in stationary conditions for
7 days at 28 ◦C in a Herstin–Schramm (H–S) medium. The medium was composed of 2%
glucose (w/v; Chempur, Poland), 0.5% yeast extract (w/v; VWR, USA), 0.5% bacto-pepton
(w/v; Graso, Poland), 0.115% citric acid monohydricum (w/v; Stanlab, Poland), 0.27%
Na2HPO4 (w/v; Chempur, Poland), 0.05% MgSO4* 7H2O (w/v; Chempur, Poland), and
1% ethanol (Chempur, Poland). Next, the cultures were shaken to remove the bacteria
from the cellulose. To obtain 14 mm BC discs, the H–S medium was inoculated with the
released bacteria in a 24-well culture plate (Nest, China) and incubated for 7 days at 28 ◦C.
Subsequently, the BC discs were removed from the plate and purified with 0.1 M NaOH
(Chempur, Poland) at 80 ◦C. The BC discs were then washed with double-distilled water
until the neutral pH was obtained and sterilized in an autoclave. The average weight of a
cellulose disc was approximately 0.75 g and 0.007 g for wet and dry (dried for 24 h at 37 ◦C)
BC, respectively. To analyze the antimicrobial activity of the extracts, the BC discs were
soaked with the extracts (0.75 mL, 0.9 mL, or 1 mL), 1 mL of saline (positive control), or
the solvent and kept refrigerated for 24 h. The percentage concentration of the extracts
absorbed in the BC discs was calculated by the formula:
Extract concentration [%] =
EV
(WBC−DBC) + EV × 100% (2)
Abbreviations: EV—volume of the extract [ml]; WBC—weight of the wet BC disc [g]; and
DBC—weight of the dry BC disc [g].
4.3.4. Analysis of the Antimicrobial Activity of Extracts Released from the Bacterial
Cellulose Carrier
The 0.5 MF suspensions of the microorganisms were prepared and cultured onto
Mueller–Hinton agar (Biomaxima, Lublin, Poland) plates using sterile cotton swabs. The
soaked BC discs were placed onto the inoculated plates. The plates were incubated for
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24 h at 37 ◦C and zones of growth inhibitions were measured in mm. Each extract was
examined once for each strain.
4.4. Statistical Evaluation
To evaluate the impact of the plants’ extracts on bacteria growth, multiple linear
regression (MLR) was applied. Compounds contained in plants’ extracts were considered as
explanatory (independent) variables. Independent variables with p < 0.25 on the univariate
analysis were entered into the model. Additionally, to find the most significant subset
of variables, the forward selection was applied. In the case of high linear correlation
(R > 0.8) on the univariate analysis between two independent variables, the independent
variable with the higher R with the dependent variable was entered into the model. The
redundancy of the variable was accessed using the variance inflation factor (VIF). The
explanatory variables with VIF lower than 3 were included in the model. Models for which
p < 0.05 were considered significant. To determine which predictor was the most important
in the regression models, the standardized regression coefficient b and R2 incremental
were considered [61]. For the estimation of statistically significant differences in compound
contents (Tables 1 and 2), Tukey’s test was applied. Means signed with the same letter were
not significantly different (p > 0.05). All statistical analyses were performed using TIBCO
Software Inc. (2017) Statistica (data analysis software system), version 13.
5. Conclusions
Comparative studies on antimicrobial properties of extracts from five different Pa-
paveraceae species indicated C. cheilanthifolia to be the most effective against human
pathogens such as S. aureus, P. aeruginosa, and C. albicans. No direct correlation can be
found between the results of antimicrobial activity and the amount of compounds con-
tained in the extracts. The roots of C. majus, followed by C. cheilanthifolia and F. vaillantii,
had the most diverse phytochemical profile in terms of isoquinoline alkaloids, while their
aerial parts were rich in polyphenolic compounds. However, the phytochemical compo-
sition does not seem to determine the strength of the antimicrobial activity of the tested
extracts as relatively poorer C. cava and C. pumila extracts were found to be more effective
in the fight with bacterial and fungal planktonic and biofilm cells.
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